Atlas Trials

Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision.

Clinical trial NCT00392314 · COMPLETED

Trial details

NCT number
NCT00392314
Sponsor
Rambam Health Care Campus
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hodgkin Lymphoma
Start date
2006-10-01
Primary completion
2014-05-01
Enrollment
365

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.